Steven Cohen's RVMD Position Overview
Steven Cohen (via Point72 Asset Management, L.P.) currently holds 60,276 shares of Revolution Medicines, Inc. (RVMD) worth $11.29 M, representing 0.01% of the portfolio. First purchased in 2021-Q2, this medium-term investment has been held for 15 quarters.
Based on 13F filings, Steven Cohen has maintained a strategic position in RVMD, demonstrating sustained confidence in this investment. Largest addition occurred in Q4 2025, adding 446,616 shares. Largest reduction occurred in Q1 2026, reducing 446,616 shares.
Analysis based on 13F filings available since 2013 Q2
Steven Cohen's Revolution Medicines (RVMD) Holding Value Over Time
Track share changes against reported price movement
Quarterly Revolution Medicines (RVMD) Trades by Steven Cohen
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | +60,276 | New Buy | 60,276 | $187.28 |
| Q1 2026 | -446,616 | Sold Out | 0 | $0.00 |
| Q4 2025 | +446,616 | New Buy | 446,616 | $79.65 |
| Q3 2024 | -227,922 | Sold Out | 0 | $0.00 |
| Q2 2024 | +227,922 | New Buy | 227,922 | $38.81 |
| Q4 2023 | -270 | Sold Out | 0 | $0.00 |
| Q3 2023 | +270 | New Buy | 270 | $27.68 |
| Q1 2023 | -383,339 | Sold Out | 0 | $0.00 |
| Q4 2022 | +383,339 | New Buy | 383,339 | $23.82 |
| Q3 2022 | -27,667 | Sold Out | 0 | $0.00 |
| Q2 2022 | -364,431 | Reduce 92.94% | 27,667 | $19.48 |
| Q1 2022 | +392,098 | New Buy | 392,098 | $25.51 |
| Q4 2021 | -55,000 | Sold Out | 0 | $0.00 |
| Q3 2021 | -137,600 | Reduce 71.44% | 55,000 | $27.51 |
| Q2 2021 | +192,600 | New Buy | 192,600 | $31.74 |
Steven Cohen's Revolution Medicines Investment FAQs
Steven Cohen first purchased Revolution Medicines, Inc. (RVMD) in Q2 2021, acquiring 192,600 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steven Cohen has held Revolution Medicines, Inc. (RVMD) for 15 quarters since Q2 2021.
Steven Cohen's largest addition to Revolution Medicines, Inc. (RVMD) was in Q4 2025, adding 446,616 shares worth $35.57 M.
According to the latest 13F filing for Q2 2026, Steven Cohen's firm, Point72 Asset Management, L.P., owns 60,276 shares of Revolution Medicines, Inc. (RVMD), valued at approximately $11.29 M.
As of the Q2 2026 filing, Revolution Medicines, Inc. (RVMD) represents approximately 0.01% of Steven Cohen's publicly disclosed stock portfolio, making it one of their key holdings.
Steven Cohen's peak holding in Revolution Medicines, Inc. (RVMD) was 446,616 shares, as reported at the end of Q4 2025.